Previous Close | 0.0580 |
Open | 0.0430 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.0580 - 0.0580 |
52 Week Range | 0.0410 - 0.2370 |
Volume | |
Avg. Volume | 5,435 |
Market Cap | 34.325M |
Beta (5Y Monthly) | 1.67 |
PE Ratio (TTM) | 0.03 |
EPS (TTM) | 1.7800 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for HERB
Enters into Joint Venture to Commence Gold Mining in Arizona with Operations to Commence this Month: Awaits Final Preferred Dividend Decision of FINRASAN JOSE, CA, May 10, 2023 (GLOBE NEWSWIRE) -- SAN JOSE, CA--(May 10, 2023) - Yasheng Group, (OTC: HERB), an agricultural company with United States headquarters in San Jose, California, today announced financial results for the first quarter of 2023. The complete financial statements containing these results can be viewed here: https://www.otcmark
SAN JOSE, March 15, 2023 (GLOBE NEWSWIRE) -- SAN JOSE, CA--(March 15, 2023) - Yasheng Group, (OTC: HERB), an agricultural and biotech company with U.S. headquarters in San Jose, California today announced that HERB gained patent protection under the USPTO, entitled, “Method for Using Cyanobacteria to Collect Rare Earth Elements from Wastewater.” A new patent has been designed for a method of using cyanobacteria to collect rare earth elements (REE) from wastewater. This technology has great poten
Begins Raising Capital for our Subsidiary, Jove Pharmaceutics In Order to Bring Next Generation Cancer Curing Cell Therapeutics to MarketSan Jose, CA, March 01, 2023 (GLOBE NEWSWIRE) -- Yasheng Group Notifies FINRA of Plan to Pay Preferred Dividend to Common Shareholders; Begins Raising Capital for our Subsidiary, Jove Pharmaceutics In Order to Bring Next Generation Cancer Curing Cell Therapeutics to Market SAN JOSE, CA--(March 1, 2023) - Yasheng Group, (OTC: HERB), an agricultural and biotech c